TRINITY LIFE SCIENCES ANNOUNCES NEW CUSTOMER ENGAGEMENT SOLUTIONS LEVERAGING ITS DEEP COMMERCIAL INSIGHT AND RECOGNIZED TECHNOLOGY PLATFORM

Nancy Phelan Appointed SVP and Head of Customer Engagement

Waltham, MA, August 21, 2024 — Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces new Customer Engagement solutions leveraging both Trinity’s deep commercial insight and recognized technology platform. The new offerings are designed to help life sciences organizations with novel customer engagement solutions including adaptive segmentation, rep-directed guidance including target patient triggers, deep insights on healthcare provider (HCP) preferences and orchestration of activation across channels. At the helm of these new offerings is Nancy Phelan, Senior Vice President and Head of Customer Engagement.

Ms. Phelan is a recognized industry thought leader and expert on omnichannel and customer engagement, with a proven track record of pioneering digital-first and data-driven approaches. With over 25 years of experience with companies such as Novartis, Adhera Therapeutics, Bristol Meyers Squibb and Pfizer, she brings a deep expertise in customer engagement strategy and operations, globally and in major markets across specialty and primary care. Ms. Phelan also currently sits on the boards of Medexus Pharmaceuticals and FemmePharma Consumer Healthcare.

“I’m delighted to have such a passionate, data-driven expert leading one of our most important growth pillars,” said Aparna Deshpande, Senior Partner and Head of Analytics & Insights at Trinity Life Sciences. “Nancy has been on the cutting edge of both the strategy and execution of customer engagement programs within life sciences companies and can demonstrate real-world successes that dramatically show better engagement with payers, healthcare professionals (HCPs) and patients. Our Customer Engagement offerings focus on the human beings behind the data.”

The new Trinity Customer Engagement solutions will provide life sciences executives with unparalleled thought leadership and capabilities, including proven decision intelligence, leading customer engagement expertise, a modular solution ecosystem and dynamic engagement models that enable them to gain real-world acceptance of their brands and make a difference in patients’ lives.​

“It was important for me to join an organization that had the building blocks to create Customer Engagement solutions that combine strategy, insights and analytics to see connectivity across patients, physicians and payers and meaningfully help our clients achieve their commercialization ambitions,” said Nancy Phelan, SVP and Head of Customer Engagement at Trinity Life Sciences. “Trinity, with its almost 30 years’ experience in life sciences, offers expertise and sophisticated tools to allow clients to look around the corner and see what their customers need.”

Nancy Phelan Thought Leadership

Ms. Phelan will be featured in the following upcoming webinar:

Who “Owns” the Customer in Customer Engagement? – hosted by Trinity Life Sciences

• October 3 at 1 PM ET
• October 8 – 16:00 – 16:45 (UTC +8:00) – Asia/Shanghai
• October 8 – 15:00 – 15:45 CET – Europe/Berlin 

With the rising adoption of digital and virtual approaches to customer engagement, companies are facing more complexity in commercialization. Trinity’s Customer Engagement experts will discuss who “owns” the customer and how to effectively collaborate cross-functionally to drive performance. Besides Ms. Phelan, the expert panel will also include:

• Kevin Francis, Partner, Customer Engagement Strategy
• Jeff Fusco, Vice President, Customer Engagement
• Anushank Anand, Director, Marketing Analytics

About Trinity Life Sciences

With almost 30 years of expertise, a best-in-the-business team and unrivaled access to data and analytics, Trinity Life Sciences is a modern partner to companies in the life sciences industry. Trinity combines strategy, insights and analytics to help life science executives with clinical and commercial decision-making. We serve over 350 pharmaceutical, biotech and medical device clients, helping them develop the right drugs and devices for today’s market and optimize them once in market. We have a diverse staff of over 1200 people and 11 global offices across the U.S., Europe and Asia. Ultimately, we know that every decision our clients make impacts a life, and when we help our clients achieve their goals, the world benefits. To learn more about how Trinity is elevating the industry and driving evidence to action, visit TrinityLifeSciences.com.

Media Contact:

Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.